These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 22435372)

  • 21. Mitochondria: the hemi of the cell.
    Cusimano EM; Knight AR; Slusser JG; Clancy RL; Pierce JD
    Adv Emerg Nurs J; 2009; 31(1):54-62. PubMed ID: 20118854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria and degenerative disorders.
    Orth M; Schapira AH
    Am J Med Genet; 2001; 106(1):27-36. PubMed ID: 11579422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disorders of mitochondrial function.
    Debray FG; Lambert M; Mitchell GA
    Curr Opin Pediatr; 2008 Aug; 20(4):471-82. PubMed ID: 18622207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of mitochondrial dysfunction in pathogenesis of diabetic microangiopathy].
    Suzuki S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():103-10. PubMed ID: 15999693
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicine. Mitochondrial replacement, evolution, and the clinic.
    Reinhardt K; Dowling DK; Morrow EH
    Science; 2013 Sep; 341(6152):1345-6. PubMed ID: 24052294
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of mitochondria in stem cell biology.
    Nesti C; Pasquali L; Vaglini F; Siciliano G; Murri L
    Biosci Rep; 2007 Jun; 27(1-3):165-71. PubMed ID: 17484045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial diseases: beyond the magic circle.
    Dahl HH; Thorburn DR
    Am J Med Genet; 2001; 106(1):1-3. PubMed ID: 11579419
    [No Abstract]   [Full Text] [Related]  

  • 28. Mitochondrial functional complementation in mitochondrial DNA-based diseases.
    Nakada K; Sato A; Hayashi J
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1907-13. PubMed ID: 19464386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of mitochondrial dysfunction in patients with collagen VI mutations.
    Olsen BR
    Matrix Biol; 2008 May; 27(4):273. PubMed ID: 18456160
    [No Abstract]   [Full Text] [Related]  

  • 30. Mice, mitochondria and myopathy.
    Harrington M
    Lab Anim (NY); 2008 Oct; 37(10):440. PubMed ID: 18810254
    [No Abstract]   [Full Text] [Related]  

  • 31. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups.
    Gómez-Durán A; Pacheu-Grau D; López-Gallardo E; Díez-Sánchez C; Montoya J; López-Pérez MJ; Ruiz-Pesini E
    Hum Mol Genet; 2010 Sep; 19(17):3343-53. PubMed ID: 20566709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
    Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mitochondrial diseases--a new branch of the modern medicine].
    Zagoskin PP; Khvatova EM
    Vopr Med Khim; 2002; 48(4):321-36. PubMed ID: 12506607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COQ4 Mutation Leads to Childhood-Onset Ataxia Improved by CoQ10 Administration.
    Caglayan AO; Gumus H; Sandford E; Kubisiak TL; Ma Q; Ozel AB; Per H; Li JZ; Shakkottai VG; Burmeister M
    Cerebellum; 2019 Jun; 18(3):665-669. PubMed ID: 30847826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial medicine: entering the era of treatment.
    Koene S; Smeitink J
    J Intern Med; 2009 Feb; 265(2):193-209. PubMed ID: 19192036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction theory of mammalian mitochondria.
    Nakada K; Inoue K; Hayashi J
    Biochem Biophys Res Commun; 2001 Nov; 288(4):743-6. PubMed ID: 11688969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
    Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
    Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial threshold effects.
    Rossignol R; Faustin B; Rocher C; Malgat M; Mazat JP; Letellier T
    Biochem J; 2003 Mar; 370(Pt 3):751-62. PubMed ID: 12467494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diseases of the human mitochondrial oxidative phosphorylation system].
    Ruiz-Pesini E; López-Gallardo E; Dahmani Y; Herrero MD; Solano A; Díez-Sánchez C; López-Pérez M; Montoya J
    Rev Neurol; 2006 Oct 1-15; 43(7):416-24. PubMed ID: 17006861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
    Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
    Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.